Related Experiment Videos
Steroids for treating tuberculous pleurisy
1Cochrane Collaboration, Medical Research Council, PO Box 19070, Tygerberg 7505, Cape Town, South Africa, 7505. pmatchab@mrc.ac.za
The Cochrane Database of Systematic Reviews
|May 5, 2000
Summary
Corticosteroids may not be effective for treating tuberculous pleural effusion, as current evidence is insufficient. Further research is needed to determine their efficacy and safety in managing this condition.
Area of Science:
- Pulmonology
- Infectious Diseases
- Clinical Trials
Background:
- Tuberculosis (TB) of the pleura causes inflammation and fibrosis.
- Corticosteroids may mitigate inflammation but pose risks of immunosuppression.
Purpose of the Study:
- To review evidence on corticosteroid effectiveness in pleural TB.
- To investigate if HIV status influences treatment outcomes.
Main Methods:
- Searched multiple databases (Cochrane, MEDLINE, EMBASE) and contacted experts.
- Included randomized and quasi-randomized trials of adjunctive corticosteroids for TB pleurisy.
- Assessed beneficial and adverse effects.
Main Results:
- Three small trials (n=236) in HIV-negative patients were included.
- No significant difference in lung function, pleural fluid, thickening, or adhesions between groups.
- Adverse effects were minimal and did not lead to treatment discontinuation.
Conclusions:
- Insufficient evidence exists to confirm the efficacy of corticosteroids in tuberculous pleural effusion.
- More robust trials are required to establish treatment guidelines.